SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-151640
Filing Date
2017-05-01
Accepted
2017-05-01 15:36:09
Documents
6
Period of Report
2017-06-14
Effectiveness Date
2017-05-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A d198099ddef14a.htm DEF 14A 1234150
2 GRAPHIC g198099g09q82.jpg GRAPHIC 69836
3 GRAPHIC g198099g36i66.jpg GRAPHIC 6692
4 GRAPHIC g198099g66q90.jpg GRAPHIC 91849
5 GRAPHIC g198099g80g88.jpg GRAPHIC 94795
6 GRAPHIC g198099pc01.jpg GRAPHIC 4838
  Complete submission text file 0001193125-17-151640.txt   1605224
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24006 | Film No.: 17800422
SIC: 2834 Pharmaceutical Preparations